Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 16/20 | 0.63 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.53 |
| ▸ | F2 | P00734 | 1/20 | 0.51 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.51 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.51 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.51 |
| ▸ | WDR5 | P61964 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL533156 | 0.82 | ACLY (0.56) | ACLYF2PRSS1PRSS2PRSS3 | |
| SCHEMBL532942 | 0.78 | ACLY (0.51) | ACLYF2PRSS1PRSS2PRSS3 | |
| SCHEMBL532915 | 0.78 | ACLY (0.57) | ACLYWDR5 | |
| SCHEMBL21999815 | 0.78 | ACLY (1.00) | ACLYF2PRSS1PRSS2PRSS3 | |
| SCHEMBL16502990 | 0.76 | L3MBTL1 (0.62) | ACLYWDR5 | |
| SCHEMBL532815 | 0.76 | ACLY (0.53) | ACLY | |
| SCHEMBL533015 | 0.75 | ACLY (0.54) | ACLY | |
| SCHEMBL17351953 | 0.75 | ACLY (0.67) | ACLYF2PRSS1PRSS2PRSS3 | |
| SCHEMBL11650550 | 0.75 | ACLY (0.67) | ACLYF2PRSS1PRSS2PRSS3 | |
| SCHEMBL21999622 | 0.75 | ACLY (1.00) | ACLYWDR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2415760-A2 | CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2012-02-08 | — | — | EP | disclosed |
| US-7319111-B2 | Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-01-15 | — | — | US | disclosed |
| US-7319111-B2 | Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-01-15 | — | — | US | disclosed |
| US-7319111-B2 | Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-01-15 | — | — | US | disclosed |